Barr Pharmaceuticals

Barr Pharmaceuticals was an American specialty and generic drug manufacturer with operations in 30 countries. Approximately 75% of the company's revenues came from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills.

It was acquired by Teva Pharmaceutical Industries in 2008 for an estimated $7.46 billion ($11.2 billion in 2025).